NovelStem International Corp.

NovelStem International Corp.

NSTM - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$335.46K
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
NovelStem International Corp.NovelStem International Corp.-1.5-15%--0.9

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$335,461.00
Enterprise Value$2.07 Million
Earnings per Share$0.05
Beta2.47
Outstanding Shares49,332,455

Return

Return on Equity15.13%ROE
Return on Assets-1948.30%
Return on Invested Capital5.61%

Valuation & Multiples

P/E Ratio-1.54P/E Ratio
PEG1.49PEG
Price to Sales-Price to Sales
Price to Book Ratio-0.01Price to Book Ratio
Enterprise Value to Revenue-
Enterprise Value to EBIT-17.21
Enterprise Value to Net Income-7
Total Debt to Enterprise0.84
Debt to Equity-0.85Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
November 16, 2026
EPS
-$0.00
Reported
Revenue Estimate
-
Consensus analyst estimate

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About NovelStem International Corp.

2 employees
CEO: Jan H. Loeb

NovelStem International Corp. concentrates its efforts on pioneering and introducing diagnostic solutions for cancer treatment, specifically with the goal of mitigating chemotherapy resistance. The company, which commenced operations in ...